While we're making progress in phasing out animal testing in the cosmetics industry around the world, there's still a ways to ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

The advent of Artificial Intelligence (AI) technologies has introduced innovative methods into drug R&D, particularly by leveraging AI capabilities. Large language models (LLMs), a breakthrough in ...

Experts from across the toxicology field highlighted the latest research and testing methods shaping the future of the ...

VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF) , a clinical-stage biotech company dedicated to developing neurorestorative ...

The addition later this year of oral-fluid drug testing for marijuana, which typically detects use only for up to 72 hours after use, could allow truck drivers to use the drug and avoid detection ...

In his "raw" and "unflinching" book Spare, the Duke spoke in depth about his previous drug use - and it's led to questions about his US visa and whether he received 'special treatment'.

Telomir-1 reduced tumor size by 50% in a prostate cancer model and protected against chemotherapy ... tumor development…We are seeing a drug that extends cellular health while simultaneously ...

Currently, antibody candidates are analyzed individually in animal models. A large number of laboratory animals are normally used to conduct each test. This is why preclinical ... that are already ...

Currently, antibody candidates are analyzed individually in animal models. A large number of laboratory animals are normally used to conduct each test. This is why preclinical ... that are already ...

We take a look at what he's said about his drug use in the past... One drug that Harry admits taking in Spare is cannabis and in the book, he recalls his introduction to it while he was at Eton ...

Google also unveiled new open AI models for drug discovery called TxGemma, following the company’s launch of a collection of Gemini AI models for multimodal use cases in healthcare. TxGemma is ...